| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 80.463 | 76.323 | 56.303 | 58.800 | 49.616 | 28.353 | 25.851 | 24.424 | 28.135 | 23.295 |
| Total Income - EUR | 83.931 | 76.323 | 56.303 | 58.801 | 50.874 | 30.421 | 25.851 | 27.092 | 28.135 | 24.358 |
| Total Expenses - EUR | 76.146 | 75.772 | 65.044 | 63.945 | 39.802 | 19.502 | 23.125 | 23.294 | 22.808 | 36.035 |
| Gross Profit/Loss - EUR | 7.785 | 551 | -8.741 | -5.144 | 11.072 | 10.919 | 2.726 | 3.798 | 5.327 | -11.677 |
| Net Profit/Loss - EUR | 7.785 | -212 | -9.304 | -5.732 | 10.563 | 10.622 | 2.467 | 3.554 | 4.350 | -11.920 |
| Employees | 16 | 11 | 9 | 7 | 4 | 1 | 3 | 2 | 2 | 2 |
Check the financial reports for the company - Nicoară Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 17.203 | 8.990 | 4.848 | 2.427 | 661 | 840 | 410 | 1.042 | 402 | 62.024 |
| Current Assets | 30.149 | 22.290 | 28.215 | 26.692 | 40.275 | 10.082 | 9.854 | 5.183 | 11.614 | 5.368 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 26.133 | 21.687 | 27.764 | 26.344 | 40.060 | 9.971 | 9.794 | 3.857 | 6.542 | 2.578 |
| Cash | 4.016 | 604 | 451 | 347 | 216 | 111 | 60 | 1.326 | 5.072 | 2.790 |
| Shareholders Funds | -76.173 | -75.608 | -80.568 | -84.821 | -72.616 | -60.617 | -56.806 | -53.429 | -48.917 | -60.564 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 123.525 | 106.955 | 113.631 | 114.037 | 113.552 | 71.540 | 67.070 | 59.653 | 60.933 | 127.955 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8121 - 8121" | |||||||||
| CAEN Financial Year |
8121
|
|||||||||
Comments - Nicoară Med Srl